The Lung Cancer Policy Network is a global, multidisciplinary alliance working to equip and inspire policymakers around the world to make improving survival from lung cancer a policy priority.
Established in 2021, the Network brings together healthcare professionals, researchers, patient organisations and industry partners to generate and mobilise evidence for policy change. Our works spans screening, earlier detection and optimal care – covering the full lung cancer pathway.
What we do
The Network generates consensus-driven, evidence-based insights and translates them into practical recommendations for policymakers, health system leaders and advocates. We connect expertise across countries and disciplines, enabling faster progress through shared learning, aligned advocacy and coordinated action.
Policy commitments that transform care and outcomes
We move from awareness to action, driving political commitment and supporting implementation at national and international levels.
Tackle policy barriers to effective implementation
We identify and address the systemic challenges limiting progress in lung cancer outcomes, and develop practical tools to overcome them.
A global hub for shared learning and advocacy
We connect stakeholders across countries and disciplines to share insights, build alignment and amplify a collective voice for policy change.
Consensus-driven, evidence-based policy insights
We generate robust, multidisciplinary insights to inform policy development and decision-making.
How we work
The Network operates through a collaborative, structured approach:
- Consensus-led development: All outputs are shaped through multidisciplinary expert input
- Global collaboration: Members share best practice and lessons across regions and health systems
- Structured priorities: Activities are organised around key areas of lung cancer policy
- Transparent processes: All activities follow clearly defined governance principles
This ensures our outputs are both scientifically robust and genuinely useful to policymakers.
Our members
Our members represent over 100 experts from across the lung cancer and oncology community, including healthcare professionals and clinicians, researchers, patient organisations, screening specialists and industry representatives.
Member organisations
